Results 111 to 120 of about 3,549 (185)

REaCT-5G: a randomized trial of bone pain with 5-day filgrastim vs pegfilgrastim for neutropenia in breast cancer. [PDF]

JNCI Cancer Spectr
Ng TL, Greenstreet P, Stober C, Nicholls S, Shamess J, Mills N, Ibrahim M, Savard MF, Rushton M, Awan A, Sehdev S, Hilton J, Song X, Fallah P, Alqahtani N, Davoudpour D, Daigle K, MacDonald F, Vandermeer L, Taljaard M, Clemons M.   +20 more
europepmc   +1 more source

Successful Re-administration of Granulocyte Colony-Stimulating Factor Without Recurrence of Associated Vasculitis: A Case Report. [PDF]

Cureus
Teshima K, Takahashi S, Takahashi S, Fujita N, Kume M, Takahashi N.   +5 more
europepmc   +1 more source

G-CSF-induced Aortitis in an elderly woman successfully managed with prednisolone: a case report and literature review. [PDF]

Oxf Med Case Reports
Kurosawa T, Ohara M, Nakame A, Ichinose Y, Fujimoto A, Nukui A, Yamaguchi K, Asano A, Shimada H, Yokogawa H, Matsuura K, Ishiguro H, Hasebe T, Osaki A, Saeki T.   +14 more
europepmc   +1 more source

Correction to: REaCT-5G: a randomized trial of bone pain with 5-day filgrastim vs pegfilgrastim for neutropenia in breast cancer. [PDF]

JNCI Cancer Spectr
europepmc   +1 more source

Efficacy and Safety of Dose-Dense Chemotherapy in Breast Cancer: Real Clinical Data and Literature Review. [PDF]

Curr Oncol
Yanagihara K, Yoshida M, Yamakawa T, Kato S, Tamura M, Nagata K.   +5 more
europepmc   +1 more source

The use of granulocyte colony-stimulating factors in the management of breast cancer patients. [PDF]

Front Oncol
Bałata A, Szombara E, Nowecki ZI, Pogoda K.   +3 more
europepmc   +1 more source

Association Between Baseline Neutrophil Count and Febrile Neutropenia Following Docetaxel and Ramucirumab With Prophylactic Pegfilgrastim. [PDF]

Thorac Cancer
Makiguchi T, Odagiri H, Tanaka H, Taima K, Tasaka S.   +4 more
europepmc   +1 more source

Short and Long-Term Outcomes in Kidney Transplant Recipients with Neutropenia or Leukopenia Following CMV Prophylaxis. [PDF]

J Health Econ Outcomes Res
Turzhitsky V, Li Q, Ai L, Jootun M, Wang W, Beyer A, Moise P, Kolobova I.   +7 more
europepmc   +1 more source

Safety and efficacy of same-day administration of eflapegrastim in patients with early-stage breast cancer receiving chemotherapy. [PDF]

Oncologist
Modiano M, Chawla S, Vacirca JL, Crist K, Franklin H, Schwartzberg L.   +5 more
europepmc   +1 more source

Prolonged myopathy and musculoskeletal symptoms following filgrastim in a 43-Year-Old female stem cell donor: a case-based review. [PDF]

Rheumatol Int
Rogowska J, Kakowski R, Makowska J, Brzezińska O.   +3 more
europepmc   +1 more source